Atomoxetine in abstinent cocaine users: Sex differences.
Atomoxetine in abstinent cocaine users: Sex differences.
复制标题
戒除可卡因使用者中的托莫西汀：性别差异。
DOI：
10.1016/j.dib.2017.08.011
复制
发表时间：
2017
期刊：
影响因子：
1.2
通讯作者：
Sofuoglu,Mehmet
中科院分区：
文献类型：
--
作者：
DeVito,EliseE;Herman,AryehI;Konkus,NoahS;Zhang,Huiping;Sofuoglu,Mehmet
提供的数据来自对患有可卡因使用障碍(CUD)的戒断者进行的单剂量托莫西汀(40毫克和80毫克)与安慰剂的人类实验室调查的性别差异二次分析。评估主观药物效应、认知功能和心血管指标。其他地方完整地报道了主要的托莫西汀剂量分析(不考虑性别因素)(DeVito等人，2017年)[1]。
Data presented are from a sex-differences secondary analysis of a human laboratory investigation of single doses of atomoxetine (40 mg and 80 mg) versus placebo in abstinent individuals with cocaine use disorders (CUD). Subjective drug effects, cognitive performance and cardiovascular measures were assessed. The primary atomoxetine dose analyses (which do not consider sex as a factor) are reported in full elsewhere (DeVito et al., 2017) [1].